Clinical Trial Update: Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating intra-operative use of Indigo Carmine dye to delineate ill-defined tumor borders in brain tumors with ill-defined margins; completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors with Ill-defined Margins

Drugs mentioned

• Indigo Carmine (indigo carmine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Brain Tumors With Ill-defined Margins | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-12-11